Skip to main content
. Author manuscript; available in PMC: 2022 Jul 3.
Published in final edited form as: Clin Cancer Res. 2022 Jul 1;28(13):2854–2864. doi: 10.1158/1078-0432.CCR-21-3695

Figure 3.

Figure 3.

Validation of copy number against MLPA. Copy number ratio (log2) was determined for 13 MM cell lines by targeted panel sequencing and MLPA A. Comparison of copy number ratio for MM 101 patient samples for 22 common regions B, with emphasis on regions associated with poor prognosis including CDKN2C C, CKS1B D, and TP53 E.